STERIS (STE) PT Raised to $254 at Needham & Company
Needham & Company analyst Mike Matson raised the price target on STERIS (NYSE: STE) to $254.00 (from $233.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
